On heels of Lumakras da­ta drop, new KRAS idea emerges; Bris­tol My­ers, Ab­b­Vie, Ru­bius head­line busy week of re­struc­tur­ing; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Long­time End­points read­ers would know that every year, ed­i­tor-in-chief John Car­roll hand­picks a group of up-and-com­ing pri­vate biotech up­starts that are promis­ing to shake up the field — or fail loud­ly. This year’s End­points 11 will be an­nounced against a dra­mat­ic back­drop, and we’ll be pre­sent­ing the awards in per­son. Join us for the cel­e­bra­tion — fea­tur­ing a fire­side chat with No­bel Prize lau­re­ate Phillip Sharp — in Boston.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.